Reviva Pharmaceuticals Inc. is an emerging research based pharmaceutical company focused on developing a portfolio of internally discovered next generation safe and effective therapeutic drugs by using an integrated chemical genomics-based technology platform and proprietary chemistries. The company is currently focused on developing drugs for the central nervous system (CNS), cardiovascular (CV), infectious, metabolic and inflammatory diseases.
Speed without sacrificing quality is one of the hallmarks of Reviva’s product development model. The company has a strong patent portfolio and promising multiple products in the pipeline at various stages of development.